In a study published in the Journal for ImmunoTherapy of Cancer December 2019 issue1, researchers demonstrate that a baseline serum biomarker signatur...
At Immunology 2019, Myriad RBM exhibited a poster, “Combining TruCulture® and OptiMAP to Profile Human Immunity." It details the immune responses (cy...
Researchers at the Mayo Clinic used Myriad RBM’s Multi-Analyte Profile (MAP) platform to analyze 320 serum proteins in healthy control subjects and su...
An international team of researchers used Myriad RBM’s Multi-Analyte Profile (MAP) technology to identify a pattern of cardiometabolic biomarkers that...
Researchers at Brigham and Women’s Hospital, Harvard Medical School demonstrate the utility of a blood-based panel for identifying Interstitial Lung D...
Researchers at Philip Morris used Myriad RBM’s RodentMAP (Multi-Analyte Profiling) immunoassay service and other histological and functional assessmen...